Sunday, Sep 28, 2025
Search
Hyderabad
Telangana
AP News
India
World
Entertainment
Sport
Science and Tech
Business
Rewind
...
NRI
View Point
cartoon
My Space
Education Today
Reviews
Property
Lifestyle
E-Paper
NRI
View Point
cartoon
My Space
Reviews
Education Today
Property
Lifestyle
"b-1-617-2-delta-variant"
Phase 3 trial data shows Covaxin to be 77.8% effective against Covid-19
Efficacy data also demonstrates 65.2 per cent protection against the SARS-CoV-2, B.1.617.2 Delta variant, the company said in a statement while announcing its phase 3 data analysis.
Latest News
ED set to attach assets of cricketers, actors in online betting case linked to 1xBet
15 mins ago
RGUKT-Basar alumni excel in Group 1 service exams
15 mins ago
Delhi HC directs Railways to fully reimburse retired employee’s Covid medical bills
29 mins ago
Tamil Nadu stampede death toll rises to 40, 67 under treatment
2 hours ago
Devotees swarm Nirmal’s Adelli to mark conclusion of Ganganeella jatara
2 hours ago
Three Naxalites killed in encounter with security forces in Chhattisgarh’s Kanker
2 hours ago
Families return as Musi River water recedes in Hyderabad’s flood-hit areas
3 hours ago
Mancherial: Youngster swept away in stream while catching fish
3 hours ago
.